Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cariporide (HOE-642) (HOE-642), an effective NHE1 inhibitor, has inhibitory effects on the degranulation of human platelets, the formation of platelet-leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 222.00 | |
100 mg | In stock | $ 346.00 | |
500 mg | In stock | $ 819.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Cariporide (HOE-642) (HOE-642), an effective NHE1 inhibitor, has inhibitory effects on the degranulation of human platelets, the formation of platelet-leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1). |
Targets&IC50 | NHE1:30 nM |
Synonyms | HOE-642 |
Molecular Weight | 283.35 |
Formula | C12H17N3O3S |
CAS No. | 159138-80-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 79 mg/mL(278.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cariporide 159138-80-4 Membrane transporter/Ion channel Sodium Channel Sodium/hydrogen Exchanger Na+/H+ Exchanger (NHE) inhibit Sodium-hydrogen Exchanger HOE642 Inhibitor HOE 642 HOE-642 inhibitor